Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase ...
(NYSE: RNG), a global leader in AI-powered customer engagement, today announced that members of its management team are scheduled to present at the following investor conference: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results